Cargando…
Advances in the computational landscape for repurposed drugs against COVID-19
The COVID-19 pandemic has caused millions of deaths and massive societal distress worldwide. Therapeutic solutions are urgently needed, but de novo drug development remains a lengthy process. One promising alternative is computational drug repurposing, which enables the prioritization of existing co...
Autores principales: | Aronskyy, Illya, Masoudi-Sobhanzadeh, Yosef, Cappuccio, Antonio, Zaslavsky, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323501/ https://www.ncbi.nlm.nih.gov/pubmed/34339864 http://dx.doi.org/10.1016/j.drudis.2021.07.026 |
Ejemplares similares
-
Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
por: Choudhury, Chinmayee, et al.
Publicado: (2022) -
Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents
por: Han, Jinhe, et al.
Publicado: (2022) -
AI-based language models powering drug discovery and development
por: Liu, Zhichao, et al.
Publicado: (2021) -
The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
por: Qiu, Tingting, et al.
Publicado: (2021) -
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
por: Chavda, Vivek P., et al.
Publicado: (2021)